Critical role of peripheral vasoconstriction in fatal brain hyperthermia induced by MDMA (Ecstasy) under conditions that mimic human drug use

Journal of Neuroscience

Volumn 34, Issue 23, 2014, Pages 7754-7762

  Kiyatkin, Eugene A ^a   Kim, Albert H ^a   Wakabayashi, Ken T ^a   Baumann, Michael H ^a   Shaham, Yavin ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Acute intoxication; Brain temperature; MDMA; Peripheral vasoconstriction; Social interaction; Warm environment

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; BRAIN HYPERTHERMIA; BRAIN METABOLISM; BRAIN TEMPERATURE; CONTROLLED STUDY....?; DRUG USE; HISTOLOGY; HOMEOSTASIS; HYPERTHERMIA; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SKIN TEMPERATURE; SOCIAL INTERACTION; TEMPERATURE MEASUREMENT; TEMPORALIS MUSCLE; THERMOGENESIS; VASOCONSTRICTION;

ACUTE INTOXICATION; BRAIN TEMPERATURE; MDMA; PERIPHERAL VASOCONSTRICTION; SOCIAL INTERACTION; WARM ENVIRONMENT;

ANIMALS; BODY TEMPERATURE; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEVER; HALLUCINOGENS; INTERPERSONAL RELATIONS; LOCOMOTION; MUSCLE, SKELETAL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NUCLEUS ACCUMBENS; RATS; RATS, LONG-EVANS; SKIN; VASOCONSTRICTION;

EID: 84901744457     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0506-14.2014     Document Type: Article

References (58)

1. Badiani A, Belin D, Epstein D, Calu D, Shaham Y (2011) Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci 12:685-700. CrossRef Medline
2. Baumann MH, Rothman RB (2009) Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA). Int Rev Neurobiol 88:257-296. CrossRef Medline
3. Baumann MH, Wang X, Rothman RB (2007) 3,4-Methylenedioxymethamphetamine(MDMA)neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology 189:407-424. Medline
4. Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, Huestis MA (2009) Effects of dose and route of administration on pharmacokinetics of (+ or-)-3,4-methylenedioxymethamphetamine in the rat. Drug Metab Dispos 37:2163-2170. CrossRef Medline
5. Baylen CA, Rosenberg H (2006) A review of the acute subjective effects of MDMA/ecstasy. Addiction 101:933-947. CrossRef Medline
6. Blessing WW, Seaman B, Pedersen NP, Ootsuka Y (2003) Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats. J Neurosci 23:6385-6391. Medline
7. Bouso JC, Doblin R, Farré M, Alcázar MA, Gómez-Jarabo G (2008) MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. J Psychoactive Drugs 40:225-236. CrossRef Medline
8. Brown PL, Kiyatkin EA (2004) Brain hyperthermia induced by MDMA(ecstasy): modulation by environmental conditions. Eur J Neurosci 20:51-58. CrossRef Medline
9. Brown PL, Wise RA, Kiyatkin EA (2003) Brain hyperthermia is induced by methamphetamine and exacerbated by social interaction. J Neurosci 23: 3924-3929. Medline
10. Carvalho M, Carvalho F, Remião F, de Lourdes Pereira M, Pires-das-Neves R, de Lourdes Bastos M (2002) Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature. Arch Toxicol 76:166-172. CrossRef Medline
11. Check E (2004) Psychedelic drugs: the ups and downs of ecstasy. Nature 429:126-128. CrossRef Medline
12. Concheiro M, Baumann MH, Scheidweiler KB, Rothman RB, Marrone GF, Huestis MA (2014) Nonlinear pharmacokinetics of ({+/-})3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat. Drug Metab Dispos 42:119-125. CrossRef Medline
13. Davis WM, Hatoum HT, Waters IW (1987) Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (ecstasy) abuse. Alcohol Drug Res 7:123-134. Medline
14. de la Torre R, Farré M, Ortuño J, Mas M, Brenneisen R, Roset PN, Segura J, Camí J (2000) Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol 49:104-109. Medline
15. Doblin R (2002) A clinical plan for MDMA (ecstasy) in the treatment of posttraumatic stress disorder (PTSD): partnering with the FDA. J Psychoactive Drugs 34:185-194. CrossRef Medline
16. Dumont GJ, Verkes RJ (2006) A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers. J Psychopharmacol 20:176-187. CrossRef Medline
17. Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC, Woods JH (2003) Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology 166:202-211. Medline
18. Freedman RR, Johanson CE, Tancer ME (2005) Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 183:248-256. CrossRef Medline
19. Gordon CJ (2007) Thermophysiological responses to hyperthermic drugs: extrapolating from rodent to human. Prog Brain Res 162:63-79. CrossRef Medline
20. Gordon CJ, Watkinson WP, O'Callaghan JP, Miller DB (1991) Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol Biochem Behav 38:339-344. CrossRef Medline
21. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) Thepharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine(MDMA, "ecstasy"). Pharmacol Rev 55:463-508. CrossRef Medline
22. Hanson GR, Rau KS, Fleckenstein AE (2004) The methamphetamine experience: a NIDA partnership. Neuropharmacology 47 [Suppl 1]:92-100. Medline
23. Irvine RJ, Keane M, Felgate P, McCann UD, Callaghan PD, White JM (2006) Plasma drug concentrations and physiological measures in 'dance party' participants. Neuropsychopharmacology 31:424-430. CrossRef Medline
24. Iwagami Y (1996) Changes in the ultrastructure of human cells related to certain biological responses under hyperthermic culture conditions. Hum Cell 9:353-366. Medline
25. Kalant H (2001) The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ 165:917-928. Medline
26. Kiyatkin EA (2010) Brain temperature homeostasis: physiological fluctuations and pathological shifts. Front Biosci 15:73-92. CrossRef Medline
27. Kiyatkin EA (2013) The hidden side of drug action: brain temperature changes induced by neuroactive drugs. Psychopharmacology 225:765-780. CrossRef Medline
28. Kiyatkin EA, Brown PL (2004) Modulation of physiological brain hyperthermia by environmental temperature and impaired blood outflow in rats. Physiol Behav 83:467-474. CrossRef Medline
29. Kiyatkin EA, Brown PL (2005) Brain and body temperature homeostasis during sodium pentobarbital anesthesia with and without body warming in rats. Physiol Behav 84:563-570. CrossRef Medline
30. Kiyatkin EA, Sharma HS (2009) Permeability of the blood-brain barrier depends on brain temperature. Neuroscience 161:926-939. CrossRef Medline
31. Kiyatkin EA, Brown PL, Sharma HS (2007) Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur J Neurosci 26:1242-1253. CrossRef Medline
32. Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA (2008) Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monit 30:320-332. CrossRef Medline
33. Lepock JR (2003) Cellular effects of hyperthermia: relevance to the minimumdose for thermal damage. Int J Hyperthermia 19:252-266. CrossRef Medline
34. Lester SJ, Baggott M, Welm S, Schiller NB, Jones RT, Foster E, Mendelson J (2000) Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Ann Intern Med 133:969-973. CrossRef Medline
35. McCann UD, Slate SO, Ricaurte GA (1996) Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy'). Drug Saf 15:107-115. CrossRef Medline
36. Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol 135:170-180. CrossRef Medline
37. Miller DB, O'Callaghan JP (2003) Elevated environmental temperature and methamphetamine neurotoxicity. Environ Res 92:48-53. CrossRef Medline
38. Milroy CM (2011) "Ecstasy" associated deaths: what is a fatal concentration? Analysis of a case series. Forensic Sci Med Pathol 7:248-252. CrossRef Medline
39. Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R (2013) Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol 27:28-39. CrossRef Medline
40. Mogenson GJ, Jones DL, Yim CY (1980) From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14:69-97. CrossRef Medline
41. Mordenti J, Chappell W (1989) The use of interspecies scaling in toxicokinetics. In: Toxicokinetics and new drug development (Yacobi A, Kelly J, Batra V, eds), pp 42-96. New York: Pergamon.
42. Parrott AC (2013) Human psychobiology of MDMA or 'ecstasy': an overview of 25 years of empirical research. Hum Psychopharmacol 28:289-307. CrossRef Medline
43. Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates, 5 Edition. Amsterdam: Elsevier Academic.
44. Pedersen NP, Blessing WW (2001) Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. J Neurosci 21:8648-8654. Medline
45. Pentney AR (2001) An exploration of the history and controversies surrounding MDMA and MDA. J Psychoactive Drugs 33:213-221. CrossRef Medline
46. Ramamoorthy Y, Yu AM, Suh N, Haining RL, Tyndale RF, Sellers EM (2002) Reduced (+/+)-3,4-methylenedioxymethamphetamine ("ecstasy") metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro. Biochem Pharmacol 63:2111-2119. CrossRef Medline
47. Ricaurte GA, McCann UD (2001) Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons. Neurotox Res 3:85-99. CrossRef Medline
48. Ricaurte GA, Yuan J, McCann UD (2000) (+/-)3,4-Methylenedioxymethamphetamine ('ecstasy')-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5-10. CrossRef Medline
49. Romanovsky AA, Ivanov AI, Shimansky YP (2002) Selected contribution: ambient temperature for experiments in rats: a new method for determining the zone of thermal neutrality. J Appl Physiol (1985) 92:2667-2679.
50. Rowell LB (1983) Cardiovascular aspects of human thermoregulation. Circ Res 52:367-379. CrossRef Medline
51. Rusyniak DE, Ootsuka Y, Blessing WW (2008) When administered to rats in a cold environment, 3,4-methylenedioxymethamphetamine reduces brown adipose tissue thermogenesis and increases tail blood flow: effects of pretreatment with 5-HT1A and dopamine D2 antagonists. Neuroscience 154:1619-1626. CrossRef Medline
52. Satchell SC, Connaughton M (1994) Inappropriate antidiuretic hormone secretion and extreme rises in serum creatinine kinase following MDMA ingestion. Br J Hosp Med 51:495. Medline
53. Sharma HS, Ali SF (2008) Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury. Ann N Y Acad Sci 1139:242-258. CrossRef Medline
54. Sharma HS, Kiyatkin EA (2009) Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. J Chem Neuroanat 37:18-32. CrossRef Medline
55. Smirnov MS, Kiyatkin EA (2008) Fluctuations in central and peripheral temperatures associated with feeding behavior in rats. Am J Physiol Regul Integr Comp Physiol 295:R1415-R1424. CrossRef Medline
56. United Nations World Drug Report (2013) New York: United Nations.
57. Vollenweider FX, Liechti ME, Gamma A, Greer G, Geyer M (2002) Acute psychological and neurophysiological effects of MDMAin humans. J Psychoactive Drugs 34:171-184. CrossRef Medline
58. Wise RA (1989) The brain and reward. In: The neuropharmacological basis of reward (Liebman JM, Kooper SJ, eds), pp 377-424. Oxford: Oxford UP.